Picture of OssDsign AB logo

OSSD OssDsign AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m-12.37%
3m-29.51%
6m-36.38%
1yr-2.93%
Volume Change (%)
10d/3m-16.07%
Price vs... (%)
52w High-39.76%
50d MA-10.87%
200d MA-25.31%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-39.01%
Return on Equity-55.73%
Operating Margin-89.11%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of OssDsign AB EPS forecast chart

Profile Summary

OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.

Directors

Last Annual
December 31st, 2023
Last Interim
June 30th, 2024
Incorporated
February 10th, 2011
Public Since
May 24th, 2019
No. of Employees
27
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
se flag iconOMX Nordic Exchange Stockholm
Shares in Issue
97,658,920

OSSD Share Price Performance

Upcoming Events for OSSD

Q3 2024 OssDsign AB Earnings Release

Q4 2024 OssDsign AB Earnings Release

Similar to OSSD

Picture of Acarix AB logo

Acarix AB

se flag iconOMX Nordic Exchange Stockholm

Picture of AddLife AB logo

AddLife AB

se flag iconOMX Nordic Exchange Stockholm

Picture of ADDvise AB (publ) logo

ADDvise AB (publ)

se flag iconOMX Nordic Exchange Stockholm

Picture of ADDvise AB (publ) logo

ADDvise AB (publ)

se flag iconOMX Nordic Exchange Stockholm

Picture of Arcoma AB logo

Arcoma AB

se flag iconOMX Nordic Exchange Stockholm

FAQ